| Product Name | Rapamycin |
| CAS No. | 53123-88-9 |
| Purity | 99% |
| Grade Standard | Medical Standard |
| MF | C51H79NO13 |
| MW | 914.19 |
| Test Method | HPLC |
| Other Name | Rapamycin Powder |
| Appearance | White Powder |
| Brand | MT |
Product Introduction:
Sirolimus, also known as rapamycin, is a macrolide produced by the bacteria Streptomyces hygroscopicus. It has immunosuppressant functions in humans and is used to prevent rejection in organ transplantation; it is especially useful in kidney transplants. It prevents activation of T cells and B cells by inhibiting their response to interleukin-2 (IL-2). Sirolimus is also used as a coronary stent coating. Sirolimus works, in part, by eliminating old and abnormal white blood cells. Sirolimus is effective in mice with autoimmunity and in children with a rare condition called autoimmune lymphoproliferative syndrome (ALPS).
A growing body of evidence has demonstrated that although limited, rapamycin or rapalogs are beneficial for treating various diseases including cancer, diabetes, tuberous sclerosis complex, lymphangioleiomyomatosis, neurodegenerative diseases and aging.
| Product Name | Rapamycin |
| CAS No. | 53123-88-9 |
| Purity | 99% |
| Grade Standard | Medical Standard |
| MF | C51H79NO13 |
| MW | 914.19 |
| Test Method | HPLC |
| Other Name | Rapamycin Powder |
| Appearance | White Powder |
| Brand | MT |
Product Introduction:
Sirolimus, also known as rapamycin, is a macrolide produced by the bacteria Streptomyces hygroscopicus. It has immunosuppressant functions in humans and is used to prevent rejection in organ transplantation; it is especially useful in kidney transplants. It prevents activation of T cells and B cells by inhibiting their response to interleukin-2 (IL-2). Sirolimus is also used as a coronary stent coating. Sirolimus works, in part, by eliminating old and abnormal white blood cells. Sirolimus is effective in mice with autoimmunity and in children with a rare condition called autoimmune lymphoproliferative syndrome (ALPS).
A growing body of evidence has demonstrated that although limited, rapamycin or rapalogs are beneficial for treating various diseases including cancer, diabetes, tuberous sclerosis complex, lymphangioleiomyomatosis, neurodegenerative diseases and aging.
